Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Family with sequence similarity 78 member A (FAM78A) is a protein-coding gene that remains largely uncharacterized in terms of molecular function. It is implicated in pathways involving apoptosis and cell growth arrest (for example, after UV-A exposure), immune modulation in cancer (such as regulation of programmed death ligand 1 in colon cancer), and is differentially expressed in placental dysfunction and ovarian folliculogenesis. FAM78A also displays altered methylation patterns associated with aggressive tumor phenotypes in renal carcinoma and melanoma, suggesting a possible role as an epigenetic biomarker, though its protein function and mechanism are not currently elucidated. To date, there is no evidence that FAM78A serves as a direct receptor, enzyme, or known drug target, nor as the subject of pharmacological intervention[1][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Family with sequence similarity 78 member A (FAM78A).